Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, General Counsel and Secy | September 26, 2022 | September 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date September 26, 2022 · Filed September 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 189,440 |
Reported balance
After 2022-09-26 transaction · row 1
1 source rowRow 1 · 2022-09-26 · Tax withholding · Disposed 4,267 · Balance 189,440 F1: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2022 Filed Sep 28, 2022 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 4,267 | $16.81 | $71,728.27 |
DisclosureSEC source: 0001209191-22-051470 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,440 F1 · shares: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 6,635 | $23.47 | $155,723.45 |
DisclosureSEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 3 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,707 F4 · kind: Represents 6,635 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,342 F3 · kind: Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,706 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,930 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan. F2 · balance_after: Includes 11,021 restricted shares granted pursuant to the Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 27,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016882 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,497 F2 · kind: Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024, subject to the terms of the Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 27,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016882 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,945 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 13,776 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2022, twenty-five percent (25%) on March 1, 2023 and fifty percent (50%) on March 1, 2024, subject to the terms of the Plan. Read SEC document |
| September 26, 2020 Filed Sep 29, 2020 20:53 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantEmployee Stock Option (right to buy) · Derivative | 96,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0001209191-20-052356 · doc4.xml · derivative · entry 2 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 96,000 shares Expires 2023-12-26 F2 · derivative.exercise_date: Option to purchase shares of Common Stock awarded under the Plan that vests as follows: (A) 30,500 shares are exercisable if and when the Issuer's Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before the third anniversary of the grant date ("Performance End Date"); (B) 31,500 shares are exercisable if and when the Issuer's Common Stock closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 34,000 shares are exercisable if and when the Issuer's Common Stock price closes at $29 (or above) for any 40 consecutive trading days before the Performance End Date, provided that no option shares will vest prior to the one-year anniversary of the grant date. F2 · derivative.expiration_date: Option to purchase shares of Common Stock awarded under the Plan that vests as follows: (A) 30,500 shares are exercisable if and when the Issuer's Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before the third anniversary of the grant date ("Performance End Date"); (B) 31,500 shares are exercisable if and when the Issuer's Common Stock closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 34,000 shares are exercisable if and when the Issuer's Common Stock price closes at $29 (or above) for any 40 consecutive trading days before the Performance End Date, provided that no option shares will vest prior to the one-year anniversary of the grant date. Read SEC document |
| September 26, 2020 Filed Sep 29, 2020 20:53 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 21,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052356 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,394 F1 · shares: Restricted shares of the Issuer's common stock ("Common Stock") granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"). Such shares vest as follows: (i) 10,843 shares vest on the second anniversary of the grant date and (ii) 10,843 shares vest on the third anniversary of the grant date, subject to the terms of the Plan. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:01 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 22,000 | $18.93 | $416,424.80 |
DisclosureSEC source: 0001209191-20-050955 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,708 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in fifty-one (51) separate transactions with prices ranging from $18.76 to $19.28 for an average weighted sale price of $18.9284. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this section. Read SEC document |
| July 12, 2020 Filed Jul 15, 2020 00:17 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 32,413 | $17.65 | $572,089.45 |
DisclosureSEC source: 0001209191-20-042446 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,708 F1 · shares: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:26 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 1,179 | $15.53 | $18,309.87 |
DisclosureSEC source: 0001209191-20-034009 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,121 F1 · kind: Represents 1,179 shares withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionRestricted Shares Units · Derivative | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015297 · doc4.xml · derivative · entry 3 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,828 shares Expires 2027-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted Shares Units granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan. F4 · derivative.exercise_price: Each Restricted Shares Units represents the equivalent of one share of Issuer's Common Stock. F5 · derivative.exercise_date: Restricted Shares Units became payable in shares of Issuer's Common Stock and vested after satisfaction of certain performance based criteria. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 9,838 | $17.09 | $168,131.42 |
DisclosureSEC source: 0001209191-20-015297 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,300 F2 · kind: Represents 9,838 shares withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 9,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-015297 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Shares Units that converted into shares of the Issuer's common stock on a one-for-one basis upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 49,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010320 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,310 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 12,487 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2020. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023, subject to the terms of the Plan. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:57 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 2,952 | $26.12 | $77,106.24 |
DisclosureSEC source: 0001209191-19-058748 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,365 F1 · kind: Represents 2,952 shares withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 2,144 | $24.66 | $52,871.04 |
DisclosureSEC source: 0001209191-19-034352 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,317.22 F1 · kind: Represents 2,144 shares withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 21:41 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 4,608 | $30.16 | $138,984.19 |
DisclosureSEC source: 0001209191-19-018141 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,461.22 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-one (31) separate transactions with prices ranging from $29.95 to $30.57 for an average weighted sales price of $30.1615. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:38 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,289 | $36.22 | $46,690.16 |
DisclosureSEC source: 0001209191-19-012605 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,069.22 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in eleven (11) separate transactions with prices ranging from $35.98 to $36.35 for an average weighted sales price of $36.222. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:28 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 30,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010161 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,358.22 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 7,615 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| December 01, 2018 Filed Dec 4, 2018 21:57 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060908 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,896.22 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. Shares will vest in three installments on December 1, 2019, December 1, 2020 and December 1, 2021. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:56 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 18,000 | $46.95 | $845,058.60 |
DisclosureSEC source: 0001209191-18-037500 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,896.22 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $46.8950 to $47.05 for an average weighted sales price of $46.9477. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. Read SEC document |
| May 24, 2018 Filed May 24, 2018 20:42 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,000 | $27.72 Strike: $27.72 | $166,290.00 |
DisclosureSEC source: 0001209191-18-033004 · doc4.xml · derivative · entry 3 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2018 Filed May 24, 2018 20:42 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 4,143 | $46.91 | $194,348.13 |
DisclosureSEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,896.22 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,857 shares of common stock upon the net exercise of 6,000 stock options with 4,143 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise. Read SEC document |
| May 24, 2018 Filed May 24, 2018 20:42 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 6,000 | $27.72 | $166,290.00 |
DisclosureSEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,039.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:58 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 13,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015769 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,039.22 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 3,456 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantRestricted Shares Units · Derivative | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064792 · doc4.xml · derivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Underlying: Common Stock · 9,828 shares Expires 2020-05-15 F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 8,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037278 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,216.22 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:23 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 6,517 | $70.84 | $461,645.38 |
DisclosureSEC source: 0001209191-17-021381 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,229.22 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-four (24) separate transactions with prices ranging from $70.69 to $70.96 for an average weighted sales price of $70.8371. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,000 | $28.55 Strike: $28.55 | $171,270.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · derivative · entry 3 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 6,000 | $69.59 | $417,531.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,746.22 F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were sold in twenty (20) separate transactions with prices ranging from $69.50 to $69.72 for a weighted average sales price of $69.5885. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 6,000 | $28.55 | $171,270.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,746.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.